Highbridge Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-5,900
Closed -$1.09M 482
2018
Q2
$1.09M Buy
+5,900
New +$1.04M 0.02% 462
2018
Q1
Sell
-1,500
Closed -$261K 1159
2017
Q4
$261K Sell
1,500
-7,200
-83% -$1.27M ﹤0.01% 1316
2017
Q3
$1.63M Buy
8,700
+6,200
+248% +$1.1M 0.02% 476
2017
Q2
$430K Sell
2,500
-13,100
-84% -$2.13M 0.01% 803
2017
Q1
$2.56M Buy
15,600
+3,800
+32% +$631K 0.04% 408
2016
Q4
$1.73M Buy
11,800
+7,200
+157% +$1.08M 0.03% 411
2016
Q3
$766K Buy
+4,600
New +$778K 0.01% 640
2016
Q1
Sell
-6,400
Closed -$1.04M 1453
2015
Q4
$1.04M Buy
+6,400
New +$1.01M 0.02% 738
2015
Q3
Sell
-19,300
Closed -$2.96M 1504
2015
Q2
$2.96M Sell
19,300
-76,400
-80% -$12.2M 0.04% 420
2015
Q1
$15.3M Buy
95,700
+19,300
+25% +$3.04M 0.21% 136
2014
Q4
$12.2M Buy
76,400
+55,500
+266% +$8.65M 0.16% 186
2014
Q3
$2.94M Buy
20,900
+15,100
+260% +$1.97M 0.04% 394
2014
Q2
$687K Sell
5,800
-10,200
-64% -$1.18M 0.01% 661
2014
Q1
$1.97M Sell
16,000
-16,900
-51% -$2.05M 0.02% 412
2013
Q4
$3.75M Sell
32,900
-32,200
-49% -$3.66M 0.04% 313
2013
Q3
$7.29M Sell
65,100
-23,700
-27% -$2.57M 0.08% 276
2013
Q2
$8.76M Buy
+88,800
New +$9.21M 0.09% 247

Other funds holding AMGN

Highbridge Capital Management's AMGN Position: Q2 2018 in Review

Highbridge Capital Management sold out of Amgen (AMGN) in Q2 2018, closing a stake of 55,642 shares — an estimated $9.84M sold.

Highbridge Capital Management first reported a position in AMGN in Q2 2013 and held it in 16 quarters. The position peaked at $43.2M in Q3 2013. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

  • Highbridge Capital Management reported no remaining Amgen position as of Q2 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 55,642 Amgen shares in Q2 2018, an estimated $9.84M.
  • Highbridge Capital Management first reported a position in Amgen in Q2 2013 and held it in 16 quarters.
  • Highbridge Capital Management's Amgen position peaked at $43.2M in Q3 2013.
  • 1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Highbridge Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.